Atara Biotherapeutics Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 2.08, 40.1, 21.92, 49.17, 76.79 ], "ebit_estimate": [ -11.28, 25.49, 5.7, 28.13, 54.52 ], "ebitda_estimate": [ -13.3, 18.7, -4.1, null, null ], "net_income_estimate": [ -16.28, 12.32, -4.2, 22.12, 61.53 ], "per_share_eps_estimate": [ -1.19, 0.9, -0.3, 1.6, 4.41 ], "eps_nri_estimate": [ -1.19, 0.9, -0.3, 1.6, 4.41 ], "dividend_estimate": [ 2, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ 11.39, 16.8, 34.4, 52, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null ], "gross_margin_estimate": [ 69, 91, 74, 72, 74 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 10.86, 0, 6.08, 2.2 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703" ], "revenue_estimate": [ 0.37, 0.5, 0.7, 0.1 ], "ebit_estimate": [ -2.91, -2.92, -1.96, null ], "ebitda_estimate": [ -3.2, -3.4, -1.7, null ], "net_income_estimate": [ -4.06, -4.12, -3.13, null ], "per_share_eps_estimate": [ -0.32, -0.29, -0.29, -0.17 ], "eps_nri_estimate": [ -0.32, -0.29, -0.29, -0.17 ], "dividend_estimate": [ null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null ], "pretax_income_estimate": [ -7.44, -6.82, -6.45, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null ], "roa_estimate": [ null, null, null, null ], "roe_estimate": [ null, null, null, null ], "gross_margin_estimate": [ null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null ], "pettm_estimate": [ 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }